Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
The Lancet. Haematology
|
August 17, 2025
Ferritin-guided iron supplementation as an alternative or complement to prolonged blood donation intervals (FORTE): a double-blind, randomised, controlled trial
Jan H M Karregat, Amber Meulenbeld, Franke A Quee, et al.
British Journal of Haematology
|
May 29, 2010
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction
Jean-Louis H Kerkhoffs, Wim L J van Putten, Viera M J Novotny, et al.
American Journal of Hematology
|
September 20, 2016
Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory
Albertine E Donker, Charlotte C M Schaap, Vera M J Novotny, et al.
Haematologica
|
November 27, 2014
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients
Jaap J Zwaginga, Bronno van der Holt, Peter A Te Boekhorst, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
The Lancet. Haematology
|
August 17, 2025
Ferritin-guided iron supplementation as an alternative or complement to prolonged blood donation intervals (FORTE): a double-blind, randomised, controlled trial
Jan H M Karregat, Amber Meulenbeld, Franke A Quee, et al.
British Journal of Haematology
|
May 29, 2010
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction
Jean-Louis H Kerkhoffs, Wim L J van Putten, Viera M J Novotny, et al.
American Journal of Hematology
|
September 20, 2016
Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory
Albertine E Donker, Charlotte C M Schaap, Vera M J Novotny, et al.
Haematologica
|
November 27, 2014
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients
Jaap J Zwaginga, Bronno van der Holt, Peter A Te Boekhorst, et al.
Page
of 5